Tenon Medical (TNON) Common Equity (2021 - 2026)

Tenon Medical has reported Common Equity for 6 years, with the latest figure at -$1.7 million in Q2 2026.

• On a quarterly basis, Common Equity fell 125.96% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was -$1.7 million, a 125.96% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 15.59% from the prior year.
• Common Equity was -$1.7 million for Q2 2026 at Tenon Medical, down from $1.9 million in the prior quarter.
• The five-year high for Common Equity was $15.1 million in Q2 2022, with the low at -$22.7 million in Q1 2022.
• Average Common Equity over 5 years is $3.5 million, with a median of $4.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity tumbled 682.38% in 2022, then jumped 706.85% in 2025.
• Over 5 years, Common Equity stood at $6.3 million in 2022, then sank by 87.56% to $778000.0 in 2023, then surged by 667.48% to $6.0 million in 2024, then dropped by 15.59% to $5.0 million in 2025, then sank by 134.58% to -$1.7 million in 2026.
• The last three Common Equity figures came in at -$1.7 million (Q2 2026), $1.9 million (Q1 2026), and $5.0 million (Q4 2025), per Business Quant data.